BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2954597)

  • 1. Low molecular weight B cell growth factor induces proliferation of human B cell precursor acute lymphoblastic leukemias.
    Wörmann B; Mehta SR; Maizel AL; LeBien TW
    Blood; 1987 Jul; 70(1):132-8. PubMed ID: 2954597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
    Benjamin D; Bazar LS; Wallace B; Jacobson RJ
    Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunobiologic differences between normal and leukemic human B-cell precursors.
    Uckun FM; Ledbetter JA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a human B cell line that proliferates in response to B cell growth factor.
    Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
    J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells.
    Uckun FM; Fauci AS; Heerema NA; Song CW; Mehta SR; Gajl-Peczalska K; Chandan M; Ambrus JL
    Blood; 1987 Oct; 70(4):1020-34. PubMed ID: 3498517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
    Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias.
    Wörmann B; Anderson JM; Ling ZD; LeBien TW
    Leukemia; 1987 Sep; 1(9):660-6. PubMed ID: 3118114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low molecular weight B-cell growth factor on proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia.
    Findley HW; Zhou MX; Davis R; Abdul-Rahim Y; Hnath R; Ragab AH
    Blood; 1990 Feb; 75(4):951-7. PubMed ID: 2302462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight B-cell growth factor and recombinant interleukin-2 are together able to generate cytotoxic T lymphocytes with LAK activity from the bone marrow cells of children with acute lymphoblastic leukemia.
    Zhou MX; Findley HW; Ragab AH
    Blood; 1989 Sep; 74(4):1355-9. PubMed ID: 2788465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor-mediated tumor cell proliferation in hairy cell leukemia.
    Ford RJ; Yoshimura L; Morgan J; Quesada J; Montagna R; Maizel A
    J Exp Med; 1985 Sep; 162(3):1093-8. PubMed ID: 2993470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of a human B cell line utilizable for the assay of B cell growth factors.
    Warrington RJ
    J Immunol Methods; 1987 Jun; 100(1-2):117-22. PubMed ID: 3110293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL; Thorbecke GJ
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
    Ennist DL; Elkins KL; Cheng SC; Howard M
    J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
    Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
    J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.